Opinion: Broadcom Is the Canary in the AI Coal Mine -- Just Not in the Way You Think

Broadcom reported Q2 revenue of $22.2 billion, up 48% year over year and above estimates, but its full-year AI chip revenue outlook remained only "in excess of $100 billion," disappointing investors. Shares fell as much as 14% as the market used the report to reset lofty AI-related valuations, with Broadcom trading at about 37x current-year earnings and roughly 20x next year's expected earnings. The article frames the selloff as a valuation-driven correction rather than a fundamental breakdown in the AI thesis.

Analysis

The selloff looks less like a deterioration in Broadcom’s fundamentals and more like a leverage point for de-rating the entire AI infrastructure complex. When a name with this much embedded optimism misses on incremental proof rather than on actual demand, the market often uses it to compress multiples across the group — especially in adjacent “arms dealer” names where end-demand visibility is still indirect. That creates a second-order winner/loser setup: hyperscalers and platform leaders with more diversified cash generation should be relatively insulated, while the crowded semiconductor and networking basket can see forced de-risking even if their own order books are intact.

The key risk is not that AI capex is rolling over today, but that forward estimates were priced assuming near-perfect execution and a clean monetization curve by the next 2-4 quarters. If those expectations keep slipping by even a few months, the unwind can extend beyond one session because passive and quant exposure will mechanically reduce weights in the highest-multiple AI beneficiaries. That said, the move is still more valuation reset than thesis break: the underlying spend cycle remains intact, but the market is no longer willing to pay peak multiples for ambiguous guideposts.

Contrarian takeaway: this is likely the kind of air pocket that creates better entry points into quality AI beneficiaries once forced selling abates. The most attractive setup is to fade the panic in the stronger balance-sheet winners while avoiding the names that need continuous multiple expansion to justify valuation. In other words, the correction is probably broader than the fundamental damage, but narrower than the headline suggests — a classic positioning washout rather than a secular demand collapse.

Key Decisions for Investors

• Buy AVGO on weakness only after the initial post-earnings de-risking is complete; prefer staged entries over 1-3 weeks. Risk/reward improves materially if the stock holds the low-$300s, but size small because further multiple compression to the high-20s forward P/E is plausible.
• Short a basket of high-beta AI semis against a long NVDA leg for 2-6 weeks. The pair captures relative multiple compression in the more crowded names while keeping directional AI exposure; NVDA should hold up better if this is a valuation washout rather than a capex slowdown.
• Use AVGO put spreads or a call overwrite into any relief rally over the next 2-4 weeks. The immediate catalyst is exhausted, and implied volatility should stay elevated; limited-risk downside structures are preferable to outright shorting after a gap move.
• Overweight cash-generative platform winners versus AI hardware secondaries for the next quarter. The trade is to own quality earnings compounding while the market re-prices uncertain 2026-2027 AI revenue assumptions.
• Set a re-entry trigger for the broader AI complex only after management teams re-affirm capex demand and backlog visibility over the next reporting cycle. If guidance stabilizes, the group can re-rate quickly; if not, expect another 10-15% downside in the high-multiple cohort.